SAILIFE Share Price Target 2035

CAGR-based price projection for Sai Life Sciences Limited (SAILIFE) targeting 2035, derived from official NSE exchange closing prices.

Bear Case (21.7% CAGR)
Rs 9,032
2035 Target
Base Case (54.3% CAGR)
Rs 76,296
2035 Target
Bull Case (179.4% CAGR)
Rs 15,995,468
2035 Target

Current Market Snapshot

CMP: Rs 1,541.20
52W High: Rs 1,675.40
52W Low: Rs 958.65
1Y CAGR: 138.0%
3Y CAGR: 54.3%

Year-by-Year Price Projection

YearBear CaseBase CaseBull Case
2027 Rs 1,876 Rs 2,378 Rs 4,306
2028 Rs 2,283 Rs 3,668 Rs 12,032
2029 Rs 2,779 Rs 5,659 Rs 33,618
2030 Rs 3,382 Rs 8,730 Rs 93,931
2031 Rs 4,116 Rs 13,469 Rs 262,450
2032 Rs 5,010 Rs 20,779 Rs 733,304
2033 Rs 6,097 Rs 32,056 Rs 2,048,905
2034 Rs 7,421 Rs 49,455 Rs 5,724,788
2035 Rs 9,032 Rs 76,296 Rs 15,995,468

Other SAILIFE Price Targets

2025 2026 2027 2028 2030 2040 2050

Frequently Asked Questions

What is the SAILIFE share price target for 2035?

Based on historical growth analysis, the SAILIFE share price target for 2035 ranges from Rs 9,032 (conservative) to Rs 76,296 (base case) to Rs 15,995,468 (optimistic). These projections are based on trailing CAGR and should not be treated as guaranteed outcomes.

What is the current share price of SAILIFE?

The current market price of SAILIFE (Sai Life Sciences Limited) is Rs 1,541.20. The 52-week high is Rs 1,675.40 and 52-week low is Rs 958.65.

Is SAILIFE a good stock to buy for the long term?

Long-term investment decisions depend on individual risk tolerance, financial goals, and portfolio diversification. Examine the company's fundamentals, debt-to-equity ratio, promoter holding, and competitive positioning within its sector. BrokerLens provides data-driven analysis; consult a SEBI-registered financial advisor before investing.

What methodology does BrokerLens use for SAILIFE price targets?

BrokerLens computes price targets using historical Compound Annual Growth Rate (CAGR) derived from official NSE closing prices. Three scenarios are modeled: Bear (conservative at 21.7% CAGR), Base (54.3% CAGR), and Bull (optimistic at 179.4% CAGR). These are statistical projections, not guaranteed forecasts.

Disclaimer: Share price targets on BrokerLens are statistical CAGR projections based on historical NSE closing prices. They are NOT guaranteed outcomes, investment advice, or analyst recommendations. Past performance does not guarantee future results. Consult a SEBI-registered investment advisor before making investment decisions. Mutual fund and equity investments are subject to market risks.